In the News
Lou Ruvo Center Doc on Pandemic Setbacks
GAP-Net site Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas was featured on FOX5 about Alzheimer’s clinical trial setbacks due to COVID-19, and how important minority communities are to research. Click here to watch the full interview. LAS VEGAS (FOX5) — Dr. Aaron Ritter with the Cleveland Clinic Lou Ruvo Center for […]
Alzheimer’s Disease Treatment Pipeline: Hope is Trending
Dr. Jeffrey Cummings from GAP-Net site, Lou Ruovo Center for Brain Health at Cleveland Clinic in Las Vegas was interviewed by NeurologyLive about developments in Alzheimer’s disease research that are worth holding out hope for. A systematic review of Alzheimer disease (AD) treatments currently in development demonstrate the progressive emphasis on nonamyloid targets, including candidate […]
Local Columnist Surprised by Result of Memory Assessment
Below is a press release from GAP-Net site, Okanagan Clinical Trials, regarding a high profile member of the community completeing a memory assessment. Kelowna (July 21, 2020) – Maxine Dehart, local city councillor, hotelier and journalist, decided to book a memory assessment for herself after featuring Okanagan Clinical Trials as part of her Straight from DeHart column in May. […]
New Clinical Trial Aimed at Preventing Alzheimer’s Years Before Symptoms Arise
GAP-Net sites Butler Hospitals Memory and Aging Program and Rhode Island Hospitals Alzheimer’s Disease and Memory Disorders Center were featured on 10WJAR in Providence, RI about an Alzheimer’s clinical trial that looks to prevent the disease before symptoms occur. A new clinical trial is aimed at preventing Alzheimer’s years before symptoms arise. There will be […]
Brigham and Women’s gets $25 Million Donation
GAP-Net site Brigham and Women’s Center for Alzheimers Research and Treatment received a $25 million donation. Brigham and Women’s Hospital has received a $25 million gift to establish and support a new Alzheimer’s prevention program, the Boston-based organization said July 13. The gift, from Andrew and Kate Davis and the Shelby Cullom Davis Charitable Fund, will […]
COVID-19 Threatens ‘precious’ Alzheimer’s Research
GAP-Net site Brigham and Women’s CART was featured with two of their Citizen Scientists in the Boston Business Journal about COVID-related delays and the dedication of AD volunteers. Joining a clinical trial may not be the first idea that pops into your head when wondering how to make new friends after moving to a new […]
UC Irvine Awarded $14.4 Million Alzheimer’s Research Grant
GAP-Net site, UCI Mind at the University of California Irvine, was awarded an Alzheimer’s research grant by the National Institute of Health The National Institutes of Health has awarded $14.4 million to the UCI MIND institute at UC Irvine to continue its crucial work in the study of Alzheimer’s disease, for which there remains no […]
Don’t Let COVID-19 Destroy Alzheimer’s Research
GAP President John Dwyer wrote a piece in The Hill urging Congress to ensure research centers involved in Alzheimer’s clinical trials will have access to COVID-19 relief funds. COVID-19 has had a devastating impact on clinical trials and the medical research infrastructure that scientists depend upon to develop new drugs for Alzheimer’s and all the diseases we fear most. Without action, […]
Global Alzheimer’s Platform Foundation Statement on Biogen’s Submission of Aducanumab Application to the FDA
Washington D.C. (July 9, 2020) – The President of the Global Alzheimer’s Platform Foundation (GAP), John Dwyer, issued the following statement regarding Biogen’s submission of its BLA application for Aducanumab with the FDA: “The Alzheimer’s research community is looking forward to a thoughtful review of Aducanumab and ideally, approval by the FDA. This application represents a singular […]
How Alzheimer’s Clinical Trials Have Become COVID-19 Victims
GAP President, John Dwyer, and GAP-Net site Great Lakes Clinical Trial spoke on the hit Alzheimer’s clinical trials have taken since COVID-19, and the losses that will come of it. After a frustrating 2019, Alzheimer’s researchers had reason to look forward to 2020 as a year of promise. Then the pandemic struck. “Last year, seven […]